Literature DB >> 27033867

Low mechanical index contrast mode versus high mechanical index contrast mode: which is a more sensitive method for detecting Sonazoid microbubbles in the liver of normal subjects?

Hiromi Nihonmatsu1, Kazushi Numata2, Hiroyuki Fukuda1, Katsuaki Tanaka1, Mari Ooba3, Shin Maeda4.   

Abstract

PURPOSE: Using the low mechanical index (MI) contrast mode and the high MI contrast mode of contrast-enhanced ultrasonography, we evaluated which method is more sensitive for detecting Sonazoid microbubbles in the liver of normal subjects.
METHODS: Thirteen normal subjects received an intravenous bolus injection of 0.2 mL of Sonazoid. We defined the intensity difference as the intensity post-injection minus the intensity pre-injection. We evaluated the intensity difference at the portal vein using both the low MI (0.21-0.23) and the high MI (0.7-1.2) at 1 min, at every 10 min between 10 to 60 min, and at every 30 min between 60 to 300 min post-injection. The intensity difference at the liver parenchyma was also evaluated at eight points (1, 10, 30, 60, 120, 180, 240, and 300 min) using the low MI and at three points (1, 10, and 300 min) using the high MI.
RESULTS: The intensity differences at the portal vein measured using high MI were significantly higher than those measured using the low MI at each point between 1 and 240 min (P < 0.01) and at 270 min post-injection (P < 0.05). The intensity differences at the liver parenchyma measured using the high MI were also significantly higher than those measured using the low MI at each time point (P < 0.01).
CONCLUSION: Compared with the low MI, the high MI is more sensitive for detecting Sonazoid microbubbles in the liver of normal subjects.

Entities:  

Keywords:  Contrast-enhanced ultrasonography; High mechanical index contrast mode; Intensity difference; Low mechanical index contrast mode; Sonazoid microbubbles

Mesh:

Substances:

Year:  2015        PMID: 27033867     DOI: 10.1007/s10396-015-0685-6

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  21 in total

1.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.

Authors:  Kyosuke Yanagisawa; Fuminori Moriyasu; Takeo Miyahara; Miyata Yuki; Hiroko Iijima
Journal:  Ultrasound Med Biol       Date:  2007-02       Impact factor: 2.998

2.  Disposition of perfluorobutane in rats after intravenous injection of Sonazoid.

Authors:  Kim Gunnar Toft; Svein Olaf Hustvedt; Petter-Arnt Hals; Inger Oulie; Steinar Uran; Kristin Landmark; Per Trygve Normann; Tore Skotland
Journal:  Ultrasound Med Biol       Date:  2006-01       Impact factor: 2.998

3.  Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial.

Authors:  Fuminori Moriyasu; Kouichi Itoh
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

4.  Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue.

Authors:  D M Skyba; R J Price; A Z Linka; T C Skalak; S Kaul
Journal:  Circulation       Date:  1998-07-28       Impact factor: 29.690

5.  Characterization of tumor imaging with microbubble-based ultrasound contrast agent, sonazoid, in rabbit liver.

Authors:  Rira Watanabe; Manabu Matsumura; Chun-Jen Chen; Yuki Kaneda; Masayoshi Fujimaki
Journal:  Biol Pharm Bull       Date:  2005-06       Impact factor: 2.233

6.  Contrast enhanced ultrasound of hepatocellular carcinoma.

Authors:  Kazushi Numata; Wen Luo; Manabu Morimoto; Masaaki Kondo; Yosuke Kunishi; Tomohiko Sasaki; Akito Nozaki; Katsuaki Tanaka
Journal:  World J Radiol       Date:  2010-02-28

7.  Contrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions.

Authors:  Ahmed Alzaraa; Gianpiero Gravante; Wen Yuan Chung; Dhya Al-Leswas; Bruno Morgan; Ashley Dennison; David Lloyd
Journal:  Hepatol Res       Date:  2013-06-20       Impact factor: 4.288

8.  Hemodynamic changes in hepatic artery after glucose ingestion in healthy subjects and patients with cirrhosis.

Authors:  K Numata; K Tanaka; T Kiba; K Mitsui; S Saito; H Sekihara
Journal:  J Clin Ultrasound       Date:  1998 Mar-Apr       Impact factor: 0.910

9.  Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.

Authors:  Wen Luo; Kazushi Numata; Manabu Morimoto; Akito Nozaki; Yasuhiko Nagano; Kazuya Sugimori; Xiaodong Zhou; Katsuaki Tanaka
Journal:  Eur J Radiol       Date:  2008-10-18       Impact factor: 3.528

10.  Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.

Authors:  Kenichi Takizawa; Kazushi Numata; Manabu Morimoto; Masaaki Kondo; Akito Nozaki; Satoshi Moriya; Tomohiro Ishii; Takashi Oshima; Hiroyuki Fukuda; Masahiro Okada; Shigeo Takebayashi; Shin Maeda; Katsuaki Tanaka
Journal:  Eur J Radiol       Date:  2013-06-13       Impact factor: 3.528

View more
  2 in total

Review 1.  Application of new ultrasound techniques for focal liver lesions.

Authors:  Feiqian Wang; Kazushi Numata; Hiromi Nihonmatsu; Masahiro Okada; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-01-16       Impact factor: 1.314

2.  Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions.

Authors:  Yi-Hong Chou; Ja-Der Liang; Shen-Yung Wang; Shih-Jer Hsu; Jui-Ting Hu; Sien-Sing Yang; Hsin-Kai Wang; Tien-Ying Lee; Chui-Mei Tiu
Journal:  J Med Ultrasound       Date:  2019-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.